A Comparison of Primary Care and Traditional Internal Medicine Residents
NCT ID: NCT00224224
Last Updated: 2008-04-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
OBSERVATIONAL
1995-01-31
2005-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Clinical performance
2. Continuity of care
3. Utilization of resources
Clinical performance will be assessed using Health Plan Employer data and Information Set (HEDIS) performance standards. These standards were developed for the purposes of quality assessment, and in our study we will examine the following HEDIS standards:
1. Breast Cancer Screening- the proportion of women between the ages of 52 and 64 who have had a mammogram within a two year period.
2. Cervical Cancer Screening- the proportion of women between the ages of 21 and 64 who had a Pap test in the preceding 3 years.
3. Cholesterol Screening- the proportion of patients ages 20 to 39 and 40-59 who have had their cholesterol tested at least once in the past five years.
4. Asthma admission rate- the proportion of asthmatics admitted to the hospital for the care of asthma per year.
5. Diabetic Standards-
1. Admission for cellulitis/ 1000 diabetics per year.
2. Admission for diabetes/ 1000 diabetics per year.
3. Inpatient days per 100 diabetics per year.
4. Prevalence of ischemic heart disease.
5. Prevalence of severe renal disease.
6. Diabetics with \>2 hemoglobin A1C drawn per year.
Continuity of Care will be assessed by 3 different indicators:
1. The proportion of visits that are made to the designated primary care provider of the number of visits made.
2. The proportion of missed appointments of the total number of appointments.
3. The proportion of walk in visits of the total number of appointments.
Resource utilization will be assessed by examining the following:
1. Number of lab test per year per patient.
2. Number of specialty consults per year per patient.
3. Hospital admission rates per patient per year.
4. Cost to medications. Confidentiality will be maintained throughout the study. In clinical practice access to CLIMACS is limited to the medical providers and administrators by individuals access codes. Furthermore, our study will remove specific identifiers to maintain the anonymity of both the patients and residents.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients at New York Hospital who may or may not go on to be followed as outpatients at CIMA.
Exclusion Criteria
21 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Weill Medical College of Cornell University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Weill Cornell Medical College
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mary E Charlson, MD
Role: PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York Presbyterian Hospital-Weill Medical College
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9510000400 (Formerly 1095-071)
Identifier Type: -
Identifier Source: org_study_id